perindopril has been researched along with Precancerous Conditions in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Ismaeel, H; Al-Rikabi, AC; Al-Shabanah, OA; Mansour, MA | 1 |
| Fukui, H; Ikenaka, Y; Kitade, M; Kuriyama, S; Masaki, T; Namisaki, T; Noguchi, R; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
| Fukui, H; Ikenaka, Y; Imazu, H; Kuriyama, S; Nakatani, T; Noguchi, R; Tsujinoue, H; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
3 other study(ies) available for perindopril and Precancerous Conditions
| Article | Year |
|---|---|
Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver.
Topics: alpha-Fetoproteins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Captopril; Carcinoembryonic Antigen; Endostatins; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Hydroxyproline; Liver; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Metallothionein; Perindopril; Precancerous Conditions; Rats; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2011 |
Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antifibrinolytic Agents; Carcinoma, Hepatocellular; Cell Division; Drug Therapy, Combination; Endothelium, Vascular; In Vitro Techniques; Liver; Liver Neoplasms; Male; Neovascularization, Pathologic; Perindopril; Precancerous Conditions; Rats; Rats, Inbred F344; Vitamin K 2 | 2005 |
Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.
Topics: Alkylating Agents; Angiotensin-Converting Enzyme Inhibitors; Animals; Choline; Diethylnitrosamine; Disease Models, Animal; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Perindopril; Precancerous Conditions; Rats; Rats, Inbred F344; Renin-Angiotensin System | 2002 |